EIP
HAE icon

Easterly Investment Partners’s Haemonetics HAE Stock Holding History

Easterly Investment Partners’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
31,122
+1,432
+5% +$93.3K 0.13% 95
2025
Q4 		$2.38M Sell
29,690
-180
-0.6% -$12.1K 0.15% 117
2025
Q3 		$1.46M Buy
29,870
+30
+0.1% +$1.86K 0.1% 134
2025
Q2 		$2.23M Sell
29,840
-991
-3% -$65.6K 0.16% 112
2025
Q1 		$1.96M Buy
+30,831
New +$2.1M 0.16% 111

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Easterly Investment Partners's HAE Position: Q1 2026 in Review

Easterly Investment Partners increased its Haemonetics (HAE) stake by 4.8% in Q1 2026, buying an estimated $93.3K and bringing the position to 31,122 shares worth $1.72M. The position accounts for 0.13% of the portfolio, ranked #95.

Easterly Investment Partners first reported a position in HAE in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.38M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

  • Easterly Investment Partners held 31,122 shares of Haemonetics worth $1.72M as of Q1 2026.
  • Easterly Investment Partners bought 1,432 Haemonetics shares in Q1 2026, an estimated $93.3K.
  • Haemonetics made up 0.13% of Easterly Investment Partners's portfolio in Q1 2026, its #95 holding.
  • Easterly Investment Partners first reported a position in Haemonetics in Q1 2025 and has held it in 5 quarters since.
  • Easterly Investment Partners's Haemonetics position peaked at $2.38M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Easterly Investment Partners's 13F filing for Q1 2026, filed 11 May 2026.